EXAS
EXACT SCIENCES CORP
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$104.91
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.34x
- Price / sales
- 6.17x
- Price / cash flow
- 40.75x
Enterprise value
- Enterprise value
- $21.6B
- EV / sales
- 6.65x
- EV / EBITDA
- 506.53x
- EV / EBIT
- -107.71x
- Market cap
- $20.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025